Use of embolic protection devices during saphenous vein graft (SVG) interventions is associated with an increase in procedural complications without corresponding improvements in clinical outcomes for ...

Please provide your email address to receive an email when new articles are posted on . Routine cerebral embolic protection did not reduce stroke in patients undergoing transcatheter aortic valve ...

EmStop, Inc., a cardiovascular medical device company, announced the initiation of the CAPTURE-2 Investigational Device Exemption (IDE) clinical trial in support of the company's mission to develop ...

CHICAGO, IL—Cerebral embolic protection devices are infrequently used during transcatheter aortic valve implantation procedures in the United States, and new data suggest their use does not appear to ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — In PROTECTED TAVR, the largest-ever randomized trial of transcatheter aortic valve replacement, ...

WASHINGTON -- An embolic protection device deployed during transcatheter aortic valve replacement (TAVR) caught plenty of material but without any impact on subclinical or clinical outcomes, the ...

EmStop has initiated the CAPTURE-2 IDE clinical trial to support the firm’s mission to develop an embolic protection system ...

WASHINGTON, DC — Are surrogate end points enough to recommend a treatment that seems safe but hasn't "worked" by clinical-trial standards, but many agree ought to work? A pair of catheter-delivered ...

United States Embolic Protection Device Market is expected to reach US$ 650 million by 2033 from US$ 360 million in 2024, with a CAGR of 6.96% from 2025 to 2033. Rising cardiovascular operations, ...

A small-profile embolic protection filter is designed to allow the capture and removal of dislodged embolic material during cardiovascular interventions. An embolic protection filter that will soon ...

ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

The recall was initiated following reports of 9 device malfunctions. Cardiovascular Systems Inc. has issued a voluntary recall of unused WIRION ® Embolic Protection systems due to complaints of filter ...